+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Access for Hemodialysis Market by Access Type (Arteriovenous Fistula, Arteriovenous Graft, Central Venous Catheter), Product Type (Accessories, Catheters, Grafts), Material, End User, Patient Age Group - Global Forecast 2025-2030- Product Image
Vascular Access for Hemodialysis Market by Access Type (Arteriovenous Fistula, Arteriovenous Graft, Central Venous Catheter), Product Type (Accessories, Catheters, Grafts), Material, End User, Patient Age Group - Global Forecast 2025-2030- Product Image
New

Vascular Access for Hemodialysis Market by Access Type (Arteriovenous Fistula, Arteriovenous Graft, Central Venous Catheter), Product Type (Accessories, Catheters, Grafts), Material, End User, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 189 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6148186
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Deep dive into the dynamic field of hemodialysis vascular access showcasing clinical imperatives, patient-centric care requirements and foundational market drivers

Vascular access serves as the essential gateway for delivering life-sustaining hemodialysis treatment to patients with end-stage renal disease. At its core, the selection and maintenance of access modalities impact not only clinical outcomes but also the patient experience, influencing rates of infection, patency and long-term survival. A deeper understanding of the hemodialysis access landscape is critical for healthcare providers, device manufacturers and policy makers alike, since incremental improvements in access technologies can translate into significant gains in safety, cost efficiency and quality of life.

As the global burden of chronic kidney disease continues to rise, the imperative to optimize vascular access strategies has never been greater. Arteriovenous fistulae, grafts and central venous catheters each present distinct risk-benefit profiles, requiring a nuanced appreciation of patient anatomy, comorbidities and treatment preferences. Simultaneously, rapid advancements in biomaterials, coating chemistries and procedural protocols are reshaping best practices and redefining performance benchmarks. The convergence of emerging technologies and evolving clinical guidelines underscores the need for an integrated, data-driven approach to access management.

This introduction lays the foundation for a comprehensive evaluation of market drivers, technological breakthroughs and regulatory influences that collectively shape the global hemodialysis vascular access sector. By establishing a clear contextual framework, this section ensures that subsequent analysis builds upon a shared understanding of key terms, stakeholder motivations and overarching industry dynamics.

Revolutionary breakthroughs in material science, device design and procedural protocols are transforming hemodialysis vascular access to optimize patient outcomes and streamline clinical workflows

The hemodialysis vascular access market is experiencing a wave of transformation driven by innovations in device architecture, biomaterial engineering and digital integration. Novel grafts incorporating bioresorbable polymers and endothelial-promoting surfaces have demonstrated the capacity to reduce thrombosis and extend patency. Concurrently, antimicrobial-impregnated catheters and heparin-bonded surfaces are actively mitigating infection risks, addressing one of the most persistent clinical challenges in long-term access.

Comprehensive analysis of cumulative impact of upcoming United States tariffs in 2025 on hemodialysis vascular access device supply chains and cost structures

Escalating trade tensions have placed a spotlight on the impact of tariffs on critical raw materials, device components and finished hemodialysis access products. With the United States poised to implement new tariff schedules in 2025, manufacturers are evaluating the cumulative cost implications across supply chains that span global suppliers of polymers, stainless steel and specialized tubing. Analytical models indicate that even modest tariff increases could trigger cost pass-through to providers, potentially constraining reimbursement margins and elevating pressure on capital budgets.

Deep insights into multifaceted segmentation of the hemodialysis vascular access market unveiling patterns across access type, product, material, end user and patient demographics

Segment analysis reveals a multifaceted landscape in which access type, product form factor, material composition, end user environment and patient age group all intersect to shape market opportunities. Within the access type framework, arteriovenous fistulae maintain prominence due to their superior long-term performance, while arteriovenous grafts address cases where native vessels are unsuitable. Central venous catheters, encompassing non-tunneled, peripherally inserted and tunneled variants, remain indispensable for acute initiation and vascular bridging strategies.

From a product perspective, the accessory segment-comprised of extension sets and heparin caps-aligns with providers’ needs for reliable operational workflows, while catheter subtypes respond to both short- and long-term access requirements. Graft offerings, spanning biological and synthetic materials, continue to evolve in tandem with novel surface chemistries. Needle designs, available in double-lumen and single-lumen configurations, reflect ongoing efforts to optimize flow dynamics and patient comfort.

Polymer selection remains central, with polytetrafluoroethylene, polyurethane and silicone each providing distinct mechanical and biocompatibility profiles. End user segmentation underscores the importance of procedural setting, as ambulatory surgical centers-whether chain-affiliated or independent-target efficiency, free-standing and hospital-based dialysis centers balance throughput with clinical oversight, and private and public hospitals integrate access management into broader care pathways. Finally, adult patient cohorts drive volume adoption, while pediatric subgroups-classified into adolescent and child-demand specialized approaches that account for anatomical and developmental considerations.

Strategic evaluation of regional dynamics across Americas, Europe, Middle East & Africa and Asia-Pacific revealing drivers, challenges and growth enablers in vascular access

Regional dynamics illuminate the divergent forces shaping adoption, reimbursement and innovation. In the Americas, advanced healthcare infrastructures, robust reimbursement models and significant research investment continue to accelerate technology uptake. The United States, in particular, remains a focal point for clinical trials and strategic partnerships aimed at next-generation vascular constructs.

Europe, the Middle East and Africa present a complex mosaic of regulatory frameworks, public health initiatives and economic heterogeneity. While Western Europe benefits from harmonized standards and established reimbursement pathways, emerging markets in the region are prioritizing access to care through policy reforms and localized manufacturing efforts. Stakeholder collaboration across national boundaries is increasingly crucial to overcoming cost constraints and distribution challenges.

Asia-Pacific stands out for its rapid expansion of hemodialysis capacity, driven by rising prevalence of chronic kidney disease, government-led infrastructure investments and growing awareness of access-related complications. Markets across East and Southeast Asia are witnessing accelerated adoption of innovative graft materials and coated catheters, underscored by a strong appetite for training programs and consortium-led clinical evaluations.

Critical profiling of leading industry players showcasing their core competencies, innovation pathways, partnership strategies and competitive positioning in vascular access market

A cadre of leading medical device companies is actively defining the competitive contours of the vascular access market through targeted investments in R&D, strategic alliances and portfolio diversification. Established players have secured regulatory clearances for next-generation graft scaffolds incorporating biologic coatings, while simultaneously advancing antimicrobial catheter platforms through co-development agreements.

Innovation roadmaps highlight milestones such as the launch of heparin-bonded catheters with extended dwell capabilities and the introduction of novel percutaneous fistula creation systems. Partnerships with academic centers and clinical research networks are accelerating evidence generation, facilitating payer engagement and informing guideline updates. At the same time, emerging challengers are leveraging digital platforms to offer remote monitoring solutions, integrating sensor-equipped catheters that provide real-time flow metrics and early complication alerts.

Mergers and acquisitions continue to reshape the landscape, with synergistic combinations targeting complementary technologies and geographic expansion. Licensing agreements for biomaterial patents underscore a broader trend toward open innovation and shared risk frameworks. Collectively, these strategic maneuvers reflect a market in which differentiation is increasingly predicated on the ability to deliver holistic, outcome-driven access solutions.

Actionable strategic recommendations for industry leaders to enhance device innovation, strengthen clinical adoption, optimize supply chain resilience and drive sustainable market growth

To capitalize on emerging opportunities, industry leaders should prioritize a multipronged approach. First, investments in advanced biomaterials and coating technologies can deliver tangible clinical benefits by reducing infection rates and prolonging device longevity. Collaborative development models with clinical investigators will expedite validation and facilitate smoother regulatory pathways.

Second, strengthening integration with digital health solutions-such as sensor-enabled catheters and predictive analytics platforms-will enhance post-procedure monitoring and create value-added service models. Third, geographic diversification of manufacturing footprints can mitigate tariff exposure and supply chain disruptions, while fostering closer alignment with local regulatory requirements.

Fourth, targeted educational initiatives for nephrologists, vascular surgeons and nursing teams will drive best-practice adoption and optimize patient selection protocols. Finally, an increased focus on pediatric and adolescent populations should guide product adaptation and clinical training, ensuring that specialized solutions meet the nuanced needs of younger cohorts.

In-depth overview of research methodology highlighting rigorous data collection, validation techniques, analytical frameworks and triangulation approaches underpinning this comprehensive market study

This study employs a structured, multi-phase research methodology designed to ensure data integrity and analytical rigor. Initial desk research encompassed an extensive review of peer-reviewed journals, clinical trial registries, regulatory filings and corporate disclosures. Secondary data points were mapped against a proprietary database of global hospital procedure volumes and reimbursement schedules to contextualize access utilization trends.

Primary research involved in-depth interviews with key opinion leaders, including interventional nephrologists, vascular surgeons, procurement directors and clinical supply chain managers. These qualitative insights were synthesized alongside quantitative survey data to validate assumptions, reconcile conflicting viewpoints and illuminate emerging adoption barriers.

Analytical frameworks such as SWOT analyses, PESTEL evaluations and Porter’s Five Forces were applied to assess competitive dynamics and market attractiveness. Data triangulation techniques were employed to cross-verify findings across multiple sources, while sensitivity analyses evaluated the impact of variable inputs, including tariff adjustments and demographic shifts. This layered approach underpins the report’s conclusions and ensures actionable, evidence-based guidance.

Concise synthesis of key findings emphasizing emerging opportunities, overarching challenges and strategic imperatives guiding stakeholders in hemodialysis vascular access domain

The evidence presented in this report confirms that the hemodialysis vascular access market is at an inflection point, characterized by rapid technological progress, evolving policy landscapes and heightened clinical demands. Innovations in biomaterials and device architecture are redefining performance standards, while digital integration is unlocking new paradigms in patient monitoring and complication management.

Regulatory and tariff considerations underscore the need for supply chain agility and localized manufacturing strategies. Market segmentation analysis reveals pockets of unmet need, particularly in pediatric cohorts and specialized end user environments. Regional insights highlight distinct growth trajectories: mature markets are focusing on incremental improvements and reimbursement alignment, whereas emerging regions emphasize capacity expansion and cost containment.

Competitive intensity is escalating as established players and disruptors vie for leadership through strategic partnerships, M&A activity and open innovation models. Stakeholders who proactively align product development with clinical priorities, governmental policies and patient-centric metrics will be best positioned to navigate the complexities ahead.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Access Type
    • Arteriovenous Fistula
    • Arteriovenous Graft
    • Central Venous Catheter
      • Non-Tunneled
      • Peripherally Inserted Central Catheter
      • Tunneled
  • Product Type
    • Accessories
      • Extension Sets
      • Heparin Caps
    • Catheters
      • Non-Tunneled
      • Peripherally Inserted Central Catheter
      • Tunneled
    • Grafts
      • Biological
      • Synthetic
    • Needles
      • Double Lumen
      • Single Lumen
  • Material
    • Polytetrafluoroethylene
    • Polyurethane
    • Silicone
  • End User
    • Ambulatory Surgical Centers
      • Chain
      • Independent
    • Dialysis Centers
      • Free-Standing
      • Hospital Based
    • Hospitals
      • Private
      • Public
  • Patient Age Group
    • Adults
    • Pediatrics
      • Adolescent
      • Child
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Teleflex Incorporated
  • Becton, Dickinson and Company
  • AngioDynamics, Inc.
  • Merit Medical Systems, Inc.
  • W. L. Gore & Associates, Inc.
  • Medtronic plc
  • Baxter International Inc.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of bioengineered arteriovenous grafts integrated with antimicrobial nanoparticles to reduce infection risk
5.2. Emergence of telemonitoring-enabled vascular access devices leveraging IoT sensors for real-time thrombosis risk assessment
5.3. Integration of artificial intelligence-driven ultrasound analytics for predictive surveillance of vascular access patency in hemodialysis patients
5.4. Development of drug-eluting catheters with sustained-release antiproliferative coatings to minimize neointimal hyperplasia in dialysis access
5.5. Expansion of percutaneous endovascular fistula creation procedures offering minimally invasive options compared to surgical arteriovenous fistula formation
5.6. Advancements in biodegradable stent technologies tailored for hemodialysis vascular access to reduce long-term foreign body complications
5.7. Surge in partnerships between dialysis centers and vascular access startups to accelerate adoption of remote monitoring solutions
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Vascular Access for Hemodialysis Market, by Access Type
8.1. Introduction
8.2. Arteriovenous Fistula
8.3. Arteriovenous Graft
8.4. Central Venous Catheter
8.4.1. Non-Tunneled
8.4.2. Peripherally Inserted Central Catheter
8.4.3. Tunneled
9. Vascular Access for Hemodialysis Market, by Product Type
9.1. Introduction
9.2. Accessories
9.2.1. Extension Sets
9.2.2. Heparin Caps
9.3. Catheters
9.3.1. Non-Tunneled
9.3.2. Peripherally Inserted Central Catheter
9.3.3. Tunneled
9.4. Grafts
9.4.1. Biological
9.4.2. Synthetic
9.5. Needles
9.5.1. Double Lumen
9.5.2. Single Lumen
10. Vascular Access for Hemodialysis Market, by Material
10.1. Introduction
10.2. Polytetrafluoroethylene
10.3. Polyurethane
10.4. Silicone
11. Vascular Access for Hemodialysis Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.2.1. Chain
11.2.2. Independent
11.3. Dialysis Centers
11.3.1. Free-Standing
11.3.2. Hospital Based
11.4. Hospitals
11.4.1. Private
11.4.2. Public
12. Vascular Access for Hemodialysis Market, by Patient Age Group
12.1. Introduction
12.2. Adults
12.3. Pediatrics
12.3.1. Adolescent
12.3.2. Child
13. Americas Vascular Access for Hemodialysis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Vascular Access for Hemodialysis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Vascular Access for Hemodialysis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Fresenius Medical Care AG & Co. KGaA
16.3.2. B. Braun Melsungen AG
16.3.3. Terumo Corporation
16.3.4. Teleflex Incorporated
16.3.5. Becton, Dickinson and Company
16.3.6. AngioDynamics, Inc.
16.3.7. Merit Medical Systems, Inc.
16.3.8. W. L. Gore & Associates, Inc.
16.3.9. Medtronic plc
16.3.10. Baxter International Inc.
17. Research AI18. Research Statistics19. Research Contacts20. Research Articles21. Appendix
List of Figures
FIGURE 1. VASCULAR ACCESS FOR HEMODIALYSIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. VASCULAR ACCESS FOR HEMODIALYSIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. VASCULAR ACCESS FOR HEMODIALYSIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. VASCULAR ACCESS FOR HEMODIALYSIS MARKET: RESEARCHAI
FIGURE 26. VASCULAR ACCESS FOR HEMODIALYSIS MARKET: RESEARCHSTATISTICS
FIGURE 27. VASCULAR ACCESS FOR HEMODIALYSIS MARKET: RESEARCHCONTACTS
FIGURE 28. VASCULAR ACCESS FOR HEMODIALYSIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. VASCULAR ACCESS FOR HEMODIALYSIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ARTERIOVENOUS FISTULA, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ARTERIOVENOUS GRAFT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ARTERIOVENOUS GRAFT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NON-TUNNELED, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NON-TUNNELED, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY TUNNELED, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY TUNNELED, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY EXTENSION SETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY EXTENSION SETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HEPARIN CAPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HEPARIN CAPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NON-TUNNELED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NON-TUNNELED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL CATHETER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY TUNNELED, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY TUNNELED, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DOUBLE LUMEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY SINGLE LUMEN, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY POLYURETHANE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY SILICONE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY SILICONE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY FREE-STANDING, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY FREE-STANDING, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITAL BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRIVATE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PUBLIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CHILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CHILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 167. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 168. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 169. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 170. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 171. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 174. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 175. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 176. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 177. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 178. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 179. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 180. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 181. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 182. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 183. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 184. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 185. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 186. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 187. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2018-2024 (USD MILLION)
TABLE 188. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2025-2030 (USD MILLION)
TABLE 189. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 190. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 191. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 192. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 193. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 194. CANADA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 195. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 196. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 197. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 198. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 199. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 202. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 203. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 208. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 209. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 210. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 211. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2018-2024 (USD MILLION)
TABLE 216. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2025-2030 (USD MILLION)
TABLE 217. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 220. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 221. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 222. MEXICO VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 261. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 262. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY DIALYSIS CENTERS, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 274. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 275. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 276. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 277. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 278. ARGENTINA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESS TYPE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CENTRAL VENOUS CATHETER, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY ACCESSORIES, 2025-2030 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2018-2024 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY CATHETERS, 2025-2030 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2018-2024 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY GRAFTS, 2025-2030 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2018-2024 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY NEEDLES, 2025-2030 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY MATERIAL, 2025-2030 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2024 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA VASCULAR ACCESS FOR HEMODIALYSIS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2025-2030 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Vascular Access for Hemodialysis Market report include:
  • Fresenius Medical Care AG & Co. KGaA
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Teleflex Incorporated
  • Becton, Dickinson and Company
  • AngioDynamics, Inc.
  • Merit Medical Systems, Inc.
  • W. L. Gore & Associates, Inc.
  • Medtronic plc
  • Baxter International Inc.

Related Topics

Related Reports

Pediatric Hemodialysis Systems Market by Modality (Continuous Renal Replacement Therapy, Hemodiafiltration, Hemodialysis), End User (Dialysis Clinics, Home Care Settings, Hospitals), Disposables, Technology, Vascular Access, Age Category - Global Forecast 2025-2030 - Product Image

Pediatric Hemodialysis Systems Market by Modality (Continuous Renal Replacement Therapy, Hemodiafiltration, Hemodialysis), End User (Dialysis Clinics, Home Care Settings, Hospitals), Disposables, Technology, Vascular Access, Age Category - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
U.S. Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report by Raw Material (Polyester, Polytetrafluoroethylene), Region (West, Midwest), and Segment Forecasts, 2024-2030 - Product Image

U.S. Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report by Raw Material (Polyester, Polytetrafluoroethylene), Region (West, Midwest), and Segment Forecasts, 2024-2030

  • Report
  • 70 Pages
  • United States
From
Hemodialysis Catheters - Global Strategic Business Report - Product Image

Hemodialysis Catheters - Global Strategic Business Report

  • Report
  • 197 Pages
  • Global
From
Asia Pacific Hemodialysis Catheters Market Size, Share & Trends Analysis Report By Material (Polyurethane, and Silicone), By Product (Cuffed Tunneled, Non-Cuffed Tunneled, and Non-Tunneled), By Tip Configuration, By End User, By Country and Growth Forecast, 2023 - 2030 - Product Image

Asia Pacific Hemodialysis Catheters Market Size, Share & Trends Analysis Report By Material (Polyurethane, and Silicone), By Product (Cuffed Tunneled, Non-Cuffed Tunneled, and Non-Tunneled), By Tip Configuration, By End User, By Country and Growth Forecast, 2023 - 2030

  • Report
  • Asia Pacific
From
Peripheral Vascular Interventional Devices Market by Device Type (Atherectomy Devices, Balloon Catheters, Embolic Agents), Application (Hemodialysis Access, Peripheral Arterial Disease, Venous Disease), End User, Technology, Distribution Channel - Global Forecast 2025-2030 - Product Image

Peripheral Vascular Interventional Devices Market by Device Type (Atherectomy Devices, Balloon Catheters, Embolic Agents), Application (Hemodialysis Access, Peripheral Arterial Disease, Venous Disease), End User, Technology, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.